SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-092475
Filing Date
2024-04-11
Accepted
2024-04-11 07:13:31
Documents
13
Period of Report
2024-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d752930d8k.htm   iXBRL 8-K 49338
  Complete submission text file 0001193125-24-092475.txt   174685

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrtx-20240410.xsd EX-101.SCH 2830
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrtx-20240410_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrtx-20240410_pre.xml EX-101.PRE 10799
17 EXTRACTED XBRL INSTANCE DOCUMENT d752930d8k_htm.xml XML 3591
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 24837122
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)